1. [Etiopathogenesis of adolescent idiopathic scoliosis and new molecular concepts].
- Author
-
Letellier K, Azeddine B, Blain S, Turgeon I, Wang da S, Boiro MS, Moldovan F, Labelle H, Poitras B, Rivard CH, Grimard G, Parent S, Ouellet J, Lacroix G, and Moreau A
- Subjects
- Adolescent, Bone and Bones pathology, Female, Humans, Male, Muscle, Skeletal pathology, Neurosecretory Systems physiopathology, Scoliosis pathology, Sex Ratio, Scoliosis etiology, Scoliosis genetics
- Abstract
Adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis that affects a significant number of young teenagers, mainly females (0.2-6 % of the population). Historically, several hypothesis were postulated to explain the aetiology of AIS, including genetic factors, biochemical factors, mechanics, neurological, muscular factors and hormonal factors. The neuroendocrine hypothesis involving a melatonin deficiency as the source for AIS has generated great interest. This hypothesis stems from the fact that experimental pinealectomy in chicken, and more recently in rats maintained in a bipedal mode, produces a scoliosis. The biological relevance of melatonin in idiopathic scoliosis is controversial since no significant decrease in circulating melatonin level has been observed in a majority of studies. Analysis of melatonin signal transduction in musculoskeletal tissues of AIS patients demonstrated for the first time a defect occurring in a cell autonomous manner in different cell types isolated from AIS patients suffering of the most severe form of that disease. These results have led to a classification of AIS patients in three different functional groups depending on their response to melatonin, suggesting that the cause of AIS involves several genes. Molecular analysis showed that melatonin signaling dysfunction is triggered by an increased phosphorylation of Gi proteins inactivating their function. This discovery has led to development of a first scoliosis screening assay. This test, using blood sample, is currently in clinical validation process in Canada and could be used for screening children at high risk of developing AIS.
- Published
- 2007
- Full Text
- View/download PDF